Onconova Therapeutics Inc
General ticker "ONTX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $14.3M
Onconova Therapeutics Inc does not follow the US Stock Market performance with the rate: -8.5%.
Estimated limits based on current volatility of 4.3%: low 0.61$, high 0.66$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 predicted range: [0.50$, 1.19$]
- 2023-12-31 to 2024-12-30 predicted range: [0.42$, 0.99$]
Financial Metrics affecting the ONTX estimates:
- Negative: Non-GAAP EPS of -0.91 <= 0.09
- Negative: Operating Income to Revenue ratio of -0.99 <= 0.01
- Negative: Operating Cash Flow per share of -0.78 <= 0.22
- Negative: negative Net Income
- Negative: Industry Operating Cash Flow per share (median) of -0.74 <= 0.29
Short-term ONTX quotes
Long-term ONTX plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.23MM | $0.23MM | $0.23MM |
| Operating Expenses | $25.22MM | $16.72MM | $19.85MM |
| Operating Income | $-24.99MM | $-16.50MM | $-19.63MM |
| Non-Operating Income | $-0.16MM | $0.33MM | $0.66MM |
| Interest Expense | $0.00MM | $0.00MM | $0.01MM |
| R&D Expense | $16.90MM | $7.30MM | $11.41MM |
| Income(Loss) | $-25.15MM | $-16.16MM | $-18.96MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-25.16MM | $-16.16MM | $-18.96MM |
| Stockholders Equity | $6.17MM | $46.12MM | $28.31MM |
| Assets | $19.99MM | $55.48MM | $39.37MM |
| Operating Cash Flow | $-23.07MM | $-19.49MM | $-16.29MM |
| Investing Cash Flow | $-0.01MM | $-0.03MM | $0.00MM |
| Financing Cash Flow | $19.36MM | $55.56MM | $0.00MM |
| Earnings Per Share* | $-2.17 | $-0.94 | $-0.88 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.